ESC TV Today,update

 

Hello Maria, Welcome to the latest episode of ESC TV Today, a special focus issue on atrial fibrillation. Topics include: Atrial Fibrillation Burden: Clinical Relevance of a New Outcome Pulsed Field Ablation: Game Changer? Drug Treatment following Atrial Fibrillation Ablation Spotlight on the Holiday Heart Syndrome Plus, much more!   WATCH NOW Drug Treatment following Atrial Fibrillation Ablation   After AF ablation, when can anticoagulation or antiarrhythmic drugs be safely stopped? Michiel Rienstra explains how stroke risk, actual AF burden, and patient-specific factors guide post-ablation therapy, and explores the potential role of left atrial appendage closure in select cases.   WATCH NOW (9 mins)   Spotlight on the Holiday Heart Syndrome   While binge drinking can trigger atrial fibrillation, alcohol’s impact may extend far beyond isolated episodes. ESC TV Today explores the bigger picture.   WATCH NOW (3 mins)   Atrial Fibrillation Burden: Clinical Relevance of a New Outcome   What is atrial fibrillation burden and how is it measured? When does AF burden matter, and how can it guide anticoagulation or heart failure decisions? Expert Jason Andrade explains how AF burden could redefine ablation success – and practical ways to track it without implanted devices.   WATCH NOW (5 mins)   Pulsed Field Ablation: Game Changer?   What makes pulsed field ablation a game changer for atrial fibrillation, and how does it differ from conventional RF or cryo techniques? Expert Arian Sultan explains the key benefits for patients, potential limitations, and how this versatile technology is reshaping AF treatment.   WATCH NOW (5 mins)   Must-See Recent Trials   Switching from warfarin to DOAC in frail elderly patients, coronary plaque burden and CV risk in women, real-time vs. conventional Heart Team for complex CAD – find out about these important publications and more in 'Cardiology this Week'.   WATCH NOW (4 mins)   ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. Sign up for reminders   Watch previous episodes   Become a member